Business and other management consultancy activities
PHARMCONSULT AS
Revenue 2024
NOK 3.6m
Operating profit
NOK 1.6m
Equity
NOK 7.2m
Incorporated
2007
Share capital
NOK 100,000
Key figures · 2024
Current ratio
3.58
Equity ratio
86.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 45.5% | |
| Net margin (%%) | 37.8% | |
| Return on assets (%%) | 19.6% | |
| Likviditet | ||
| Current ratio | 3.58 | |
| Working capital | 2.3m | |
| Soliditet | ||
| Equity ratio (%%) | 86.5% | |
| Debt-to-equity ratio | 0.16 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.